JPMorgan Chase & Co’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $886K | Buy |
|
|||||
|
2025
Q1 | $763K | Buy |
|
|||||
|
2024
Q4 | $219K | Buy |
|
|||||
|
2024
Q3 | $9.75K | Sell |
|
|||||
|
2024
Q2 | $9.79K | Sell |
|
|||||
|
2024
Q1 | $86.4K | Buy |
|
|||||
|
2023
Q4 | $73.1K | Sell |
|
|||||
|
2023
Q3 | $2.74M | Sell |
|
|||||
|
2023
Q2 | $4.43M | Sell |
|
|||||
|
2023
Q1 | $3.47M | Buy |
|
|||||
|
2022
Q4 | $6.74M | Sell |
|
|||||
|
2022
Q3 | $7.13M | Sell |
|
|||||
|
2022
Q2 | $6.44M | Buy |
|
|||||
|
2022
Q1 | $770K | Buy |
|
|||||
|
2021
Q4 | $541K | Buy |
|
|||||
|
2021
Q3 | $536K | Buy |
|
|||||
|
2021
Q2 | $470K | Buy |
|
|||||
|
2021
Q1 | $1K | Sell |
|
|||||
|
2020
Q4 | $0 | Hold |
|
|||||
|
2020
Q3 | $0 | Hold |
|
|||||
|
2020
Q2 | $0 | Sell |
|
|||||
|
2020
Q1 | $186K | Sell |
|
|||||
|
2019
Q4 | $388K | Sell |
|
|||||
|
2019
Q3 | $233K | Sell |
|
|||||
|
2019
Q2 | $870K | Buy |
|
|||||
|
2019
Q1 | $1.47M | Buy |
|
|||||
|
2018
Q4 | $1.44M | Buy |
|
|||||
|
2018
Q3 | $2.73M | Buy |
|
|||||
|
2018
Q2 | $3.67M | Sell |
|
|||||
|
2018
Q1 | $3.33M | Buy |
|
|||||
|
2017
Q4 | $124K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $207K | Buy |
|